Accord Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?
ACCORD HLTHCARE has one hundred and thirty-nine approved drugs.
There are nine tentative approvals on ACCORD HLTHCARE drugs.
Drugs and US Patents for Accord Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accord Hlthcare | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; olmesartan medoxomil | TABLET;ORAL | 209281-002 | Feb 7, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Accord Hlthcare | TACROLIMUS | tacrolimus | OINTMENT;TOPICAL | 211688-002 | Jan 31, 2019 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Accord Hlthcare | TEMOZOLOMIDE | temozolomide | CAPSULE;ORAL | 201528-002 | Feb 27, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACCORD HLTHCARE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Here is a list of applicants with similar names.